 |
|
|
 |
May Is National Melanoma/Skin Cancer Detection and Prevention Month
May is National Melanoma/Skin Cancer Detection and Prevention Month. This month is dedicated to increasing public awareness of the importance of prevention, early detection, and treatment of skin cancer, including basal cell, squamous cell, and melanoma. The American Cancer Society estimates that in 2001, approximately 1.3 million new cases of curable basal cell and squamous cell carcinomas will be detected, approximately 51,400 new cases of malignant melanoma will be diagnosed, and an estimated 7800 persons will die from melanoma and 2000 from other skin cancers. Although death rates from basal cell and squamous cell carcinomas are low, these cancers can cause damage and disfigurement if left untreated. However, when detected early, approximately 95% of these carcinomas can be cured. more
|
|
Evidence-Based Practice: Screening For Skin Cancer - The US Preventive Services Task Force Recommendations
Malignant melanoma is often lethal, and its incidence in the United States has increased rapidly over the past 2 decades. Nonmelanoma skin cancer is seldom lethal, but, if advanced, can cause severe disfigurement and morbidity. Early detection and treatment of melanoma might reduce mortality, while early detection and treatment of nonmelanoma skin cancer might prevent major disfigurement and to a lesser extent prevent mortality. Current recommendations from professional societies regarding screening for skin cancer vary. Get the current US Preventive Services Task Force Recommendations in today's issue of Vidyya. more
|
|
|
|
Benign Paroxysmal Positional Vertigo: Condition Is Under Diagnosed, Under Treated
According to presentations made at the American Academy of Neurology, thousands of people are going untreated for one of the commonest forms of dizziness and vertigo, because doctors are unaware of how to treat and diagnose it. Despite a simple diagnostic test and speedy treatment being available, many doctors fail to spot benign paroxysmal positional vertigo (BPPV). more
|
|
Novel Therapeutic Virus Promising Treatment For A Wide Range Of Neoplastic Conditions
Encouraging results of a phase I clinical trial of PV701, a novel therapeutic virus, were reported on 13-May-2001 by Dr. Andrew Pecora of the Hackensack University Medical Center at the annual meeting of the American Society of Clinical Oncology (ASCO). The main objective of the trial was to evaluate the safety of PV701 but the results were also examined for evidence of efficacy. more
|
|
Information For Patients: Gleevec (Imatinib Mesylate)
Gleevec is a new type of cancer drug – the first of its kind developed to fight cancer by turning off an enzyme that causes cells to become cancerous and multiply. Gleevec is approved to treat a rare cancer called Chronic Myeloid Leukemia (CML),which affects between 5,000 and 8,000 patients each year. more
|
|
|
